Therapeutic-area Dossier
Reproductive Health
Therapeutic-area Dossier for Reproductive Health (reproductive health medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC…
- Brand: APO-Dutasteride
- Brand: BEMFOLA
- Brand: CAVERJECT IMPULSE
- Brand: CETROTIDE
- Brand: CLOMID
- Brand: CRINONE
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Bayer
- Sponsor: Pfizer
- Sponsor: Lupin
What is
Reproductive Health Reproductive Health covers a therapeutic area with 180 brands registered in total, of which 63 are indexable. This area encompasses medicines and treatments related to reproductive function, fertility, and hormonal management across the lifespan.
Brands registered in
Reproductive Health The top brands registered in Reproductive Health are: — APO-Dutasteride — CRINONE — ENDOMETRIN — ESTROGEL — LUVERIS — OVIDREL — PROGYNOVA — NUVARING — NEXTSTELLIS — RYEQO — SLINDA — QLAIRA
Sponsor landscape
The Reproductive Health area is served by 92 active sponsors, with major players including Bayer, Arrotex Pharmaceuticals, Pfizer, Nova Pharmaceuticals, Maple Healthcare, Lupin, Vitex Pharmaceuticals, and BlueSkyGreenEarth Herbs.
PBS and regulatory activity
Seven brands in Reproductive Health have PBS-listed items, with the latest PBS schedule date for this area being 1 May 2026. The most recent PBAC outcome in this area is dated 1 May 2025, with 14 brands holding PBAC outcomes on record. The latest AusPAR is dated 28 June 2023, with 5 brands holding AusPARs on record.